This post highlights the top three most viewed videos related to stem cell research on YouTube. These videos were all released within the last five years, and provide different, innovative angles on how stem cell research is revolutionizing our world today.
The Skin Gun
National Geographic highlights a simple idea that, backed by stem cell research, allows victims with severe burns to heal in a mere number of days. This video has gotten over 4.8 MILLION views. Wow.
Transplant Cells, Not Organs TED Talk
Dr. Susan Lim is a pioneering surgeon who performed Asia’s first successful liver transplant in 1990. In this talk at the INK conference, Dr. Lim explores the moral concern of using transplants (ie. where do donor transplants come from?), and discusses transplanting cells instead of organs. This TEDTalk has gotten over 1 million views on YouTube alone.
Stem Cells and the Future of Medicine- Research on Aging
Lawrence Goldstein, Distinguished Professor in the Department of Cellular and Molecular Medicine and the Department of Neurosciences at UCSD School of Medicine, as well as the Director of the UCSD Stem Cell Program, discusses the basic principles of stem cells. He examines the promise they offer and how they can be safely and effectively employed. This incredible video by UCTV has over 80 thousand views.
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant has been cited by prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, CBS News, and the California Institute for Regenerative Medicine (CIRM). Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, and Thermo Fisher Scientific, BioInformant is your global leader in cord blood industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.